Close

Dermira (DERM) Shares Rise as CIMZIA Phase 3 Met co-Primary Efficacy Endpoints in Plaque Psoriasis

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/24/2024

1. TSLA
2. SPOT
3. SPY
4. GM
5. AMZN
6. MSCI
7. NVDA
8. SHW
9. IBM
10. AAPL


Go back to Dermira (DERM) Shares Rise as CIMZIA Phase 3 Met co-Primary Efficacy Endpoints in Plaque Psoriasis
(NASDAQ: DERM) Delayed: 3.54 --0 (-0%)
Previous Close $3.54    52 Week High $36.34 
Open $3.54    52 Week Low $17.42 
Day High $3.54    P/E N/A 
Day Low $3.54    EPS $0.00 
Volume 1,988